logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Oncternal Therapeutics, Inc.


USPTO Granted Patents = 16



Trademarks = 3

Forward Citations = 41

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal James T Dalton (6 out of 101 patents)

silverMedal Duane Douglas Miller (5 out of 119 patents)

bronzeMedal Brian Lannutti (4 out of 18 patents)

4.  Katayoun Jessen (4 out of 8 patents)

5.  James Bradley Breitmeyer (4 out of 4 patents)

6.  Sunjoo Ahn (4 out of 20 patents)

7.  Ramesh Narayanan (3 out of 42 patents)

8.  Wei Li (3 out of 15 patents)

9.  Jean-Michel Andre Vernier (3 out of 56 patents)

10.  Stephen Evan Webber (3 out of 54 patents)

11.  Jin Wang (2 out of 175 patents)

12.  Thamarai Ponnusamy (2 out of 28 patents)

13.  Dong-Jin Hwang (2 out of 23 patents)

14.  Christopher C Coss (2 out of 12 patents)

15.  Charles B Duke (2 out of 13 patents)


16 patents:

1. 12161626 - Uses of indolinone compounds (2024-12-10),
2. 12128026 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2024-10-29),
3. 11465987 - Compounds for treatment of cancer (2022-10-11),
4. 11285132 - Uses of indolinone compounds (2022-03-29),
5. 11084811 - Compounds for treatment of cancer (2021-08-10),
6. 10865196 - Compounds for treatment of cancer (2020-12-15),
7. 10849873 - Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapy (2020-12-01),
8. 10711008 - Indoline analogs and uses thereof (2020-07-14),
9. 10646470 - Uses of indolinone compounds (2020-05-12),
10. 10597354 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2020-03-24),
11. 10351569 - Indoline analogs and uses thereof (2019-07-16),
12. 10159660 - Uses of indolinone compounds (2018-12-25),
13. 9987251 - Indolinone compounds and uses thereof (2018-06-05),
14. 9895352 - Indolinone compounds and uses thereof (2018-02-20),
15. 9822122 - Indoline analogs and uses thereof (2017-11-21),
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for the treatment of cancer. The company's pipeline includes targeted oncology drugs designed to selectively inhibit key pathways involved in tumorigenesis. Oncternal Therapeutics aims to improve the lives of cancer patients through innovative and effective treatment options.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
16 Patents

#340 in San Diego, CA

#4,620 in California

#19,271 in US

#36,634 in the World

...
San Diego, CA, United States of America

Oncternal Therapeutics, Inc.

Forward Citations = 41

25 inventors:

goldMedal James T Dalton (6 out of 101 patents)

silverMedal Duane Douglas Miller (5 out of 119 patents)

bronzeMedal Brian Lannutti (4 out of 18 patents)

4.  Katayoun Jessen (4 out of 8 patents)

5.  James Bradley Breitmeyer (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…